These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15827398)

  • 1. I-123 whole body scanning: case report and discussion.
    Klein HA; DiSibio KJ; Sims D; Singleton HC; Worthy LJ
    Clin Nucl Med; 2005 May; 30(5):312-6. PubMed ID: 15827398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 131I therapeutic efficacy is not influenced by stunning after diagnostic whole-body scanning.
    Dam HQ; Kim SM; Lin HC; Intenzo CM
    Radiology; 2004 Aug; 232(2):527-33. PubMed ID: 15286323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of post-therapy whole-body I-131 imaging in the evaluation of patients with thyroid carcinoma having undergone high-dose I-131 therapy.
    Spies WG; Wojtowicz CH; Spies SM; Shah AY; Zimmer AM
    Clin Nucl Med; 1989 Nov; 14(11):793-800. PubMed ID: 2513156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer.
    Mandel SJ; Shankar LK; Benard F; Yamamoto A; Alavi A
    Clin Nucl Med; 2001 Jan; 26(1):6-9. PubMed ID: 11139058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
    Gerard SK; Dam HQ
    Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
    [No Abstract]   [Full Text] [Related]  

  • 7. The clinical effects of thyroid stunning after diagnostic whole-body scanning with 185 MBq 131I.
    Lees W; Mansberg R; Roberts J; Towson J; Chua E; Turtle J
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1421-7. PubMed ID: 12397458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial stunning in thyroid remnant after administration of scanning dose followed by 100 mCi I-131 therapy.
    Yagcloglu H; Ozalp E; Ibis E; Aras G
    Clin Nucl Med; 1996 Apr; 21(4):340. PubMed ID: 8925630
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for sequential treatments.
    Leger AF; Pellan M; Dagousset F; Chevalier A; Keller I; Clerc J
    Br J Radiol; 2005 May; 78(929):428-32. PubMed ID: 15845937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. I-123 diagnostic thyroid tumor whole-body scanning with imaging at 6, 24, and 48 hours.
    Gerard SK; Cavalieri RR
    Clin Nucl Med; 2002 Jan; 27(1):1-8. PubMed ID: 11805475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I.
    Hilditch TE; Dempsey MF; Bolster AA; McMenemin RM; Reed NS
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):783-8. PubMed ID: 12029552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body scanning with radionuclides of iodine, and the controversy of "thyroid stunning".
    Kalinyak JE; McDougall IR
    Nucl Med Commun; 2004 Sep; 25(9):883-9. PubMed ID: 15319592
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of outcomes after (123)I versus (131)I pre-ablation imaging before radioiodine ablation in differentiated thyroid carcinoma.
    Silberstein EB
    J Nucl Med; 2007 Jul; 48(7):1043-6. PubMed ID: 17574976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insensitivity of Tc-99m pertechnetate for detecting metastases of differentiated thyroid carcinoma.
    Campbell CM; Khafagi FA
    Clin Nucl Med; 1990 Jan; 15(1):1-4. PubMed ID: 2155079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization of the thymus with therapeutic doses of radioiodine in patients with thyroid cancer.
    Michigishi T; Mizukami Y; Shuke N; Yokoyama K; Noguchi M; Watanabe Y; Matsui O; Aburano T; Tonami N; Hisada K
    Eur J Nucl Med; 1993 Jan; 20(1):75-9. PubMed ID: 8267685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Level of Agreement Between Pretherapeutic 124I PET and Intratherapeutic 131I Imaging in Detecting Iodine-Positive Thyroid Cancer Metastases.
    Ruhlmann M; Jentzen W; Ruhlmann V; Pettinato C; Rossi G; Binse I; Bockisch A; Rosenbaum-Krumme S
    J Nucl Med; 2016 Sep; 57(9):1339-42. PubMed ID: 27151981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual patterns of I-131 contamination.
    Ozguven M; Ilgan S; Arslan N; Karacalioglu AO; Yuksel D; Dundar S
    Ann Nucl Med; 2004 May; 18(3):271-4. PubMed ID: 15233290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophageal diverticulum presenting as metastatic thyroid mass on iodine-131 scintigraphy.
    Rashid K; Johns W; Chasse K; Walker M; Gupta SM
    Clin Nucl Med; 2006 Jul; 31(7):405-8. PubMed ID: 16785810
    [No Abstract]   [Full Text] [Related]  

  • 19. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
    J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidental detection of a falx meningioma on post-therapy radioiodide whole-body imaging.
    Sinha P; Conrad GR; Holzhauer M
    Clin Nucl Med; 2002 Dec; 27(12):916-7. PubMed ID: 12607886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.